STYRENIX PERFORMANCE LTD Fair Value
STYRENIX · Chemicals · Current price ₹2,013.6
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹846 | 15% ROE fading to 13% over ~10 yrs, on ₹777 book |
| Relative P/E | ₹1,470 | EPS × 14.1 peer-median P/E |
| Graham floor | ₹1,348 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is STYRENIX PERFORMANCE LTD undervalued?
DocStoX estimates the fair value of STYRENIX PERFORMANCE LTD at ₹1,121 per share, versus the current market price of ₹2,014. That puts the stock about -44.3% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is medium.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹846), Relative P/E (₹1,470), Graham floor (₹1,348). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹846 (bear) to ₹1,121 (base) to ₹1,470 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on STYRENIX PERFORMANCE LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.